Regulating the pharmaceutical industry. General public does not support value system inherent in cost effectiveness analyses.
Furniss
J
J
Zammit-Lucia
J
J
Johnson
N
N
D003362:Cost-Benefit Analysis; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D011639:Public Opinion; D006113:United Kingdom